40 'New' Psychedelic Compounds Found In More Than 25 Species of Mushrooms

40 ‘New’ Psychedelic Compounds Found In More Than 25 Species of Mushrooms

Mydecine Innovations Group says it has found 40 new compounds in at least 25 types of mushrooms with psychedelic and potentially therapeutic properties.

Ask A Psychedelic Guide

We welcome back Nick Levich for our "Ask a Psychedelic Professional" series and as part of our "Ask a Psychedelic Guide" episode.
The War On Drugs May Finally Be Over: Decriminalization Legislation Comes to Congress

The War On Drugs May Finally Be Over: Decriminalization Legislation Comes to Congress

Representatives Cori Bush and Bonnie Watson Coleman have introduced legislation to end the federal war on drugs once and for all.
Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.
University of Calgary Creates Canada’s First Chair for Psychedelic Research

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Psilocybin May Treat Phantom Limb Syndrome

80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation

Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation

Atai Life Sciences is the latest psychedelic company to announce plans to IPO. The Peter Thiel-backed biotech startup is valued at more than $2 billion.

PSY: The First American Psychedelic ETF [Excerpt]

Since Last week's episode was so long, we decided to cut it into pieces so we don't bore you guys! The ETF “seeks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index, a rules-based index that tracks the performance of companies listed in North American Exchanges that operate business models focused on the legal usage of psychedelics, cannabis, and ketamine for therapeutic purposes.” In this excerpt, we cover what the new American psychedelic ETF (PSY:NYSE) is, as well as my thoughts on it! Enjoy the mini episode! Link: https://www.defianceetfs.com/psy/ https://psychedelicspotlight.com/psy-first-u-s-psychedelic-etf/ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Website: https://thepsychedelicinvestor.com/ Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifa... https://benzinga.grsm.io/thepsychedel... DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #PSY #PsychedelicETF

MindMed To Deliver Psychedelics Directly To The Brain? (MMED / MNMD)

MindMed (MMED :NEO), (MNMD:NASDAQ), (MMQ: FRA) is testing the delivery of psychedelics compounds directly to the brain!? What is the best way to take a psychedelic medicine? Is it in a format of a pill, a film strip which dissolves under the tongue, or maybe an injection? These are the standard delivery methods we're all familiar with. But what if we could deliver a psychedelic medicine directly to the brain, and thus negate any potentially negative side effects of the drug interacting with the body? Answering this question is the purpose of a new MindMed partnership. In this episode, we'll explore MindMed's new partnership with Nextage Therapeutics, their Brain Targeting Liposome System (BTLS), and it's applications. Enjoy the episode! Link: https://mindmed.co/news/press-release/mindmed-announces-launch-of-collaboration-with-nextage-therapeutics-brain-targeting-liposome-system/ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Website: https://thepsychedelicinvestor.com/ Music: www.bensound.com Video editing: @themyaholy https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #MNMD #MindmedNews
Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.